Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $147.36M.
ENTERPRISE VALUE (EV)
$147.36M
Sionna Therapeutics, Inc.
Market Cap
$205.81M
Enterprise Value (EV)
$147.36M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Sionna Therapeutics, Inc. (SION) | $205.81M | $147.36M |
| Alector, Inc. (ALEC)vs › | $205.40M | $178.24M |
| Entrada Therapeutics, Inc. (TRDA)vs › | $207.55M | $156.81M |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $203.40M | $119.65M |
| Pro-Dex, Inc. (PDEX)vs › | $208.63M | $218.54M |
| Electra Therapeutics Inc. (ETRA)vs › | $208.65M | N/A |
| Surrozen, Inc. (SRZN)vs › | $202.04M | $106.32M |
| Compugen Ltd. (CGEN)vs › | $211.33M | $204.07M |
| Exagen Inc. (XGN)vs › | $200.28M | $201.24M |
| Prelude Therapeutics Incorporated (PRLD)vs › | $211.79M | $203.11M |
Market Cap
$205.81M
Total Debt
$0.00
Cash
$58.45M
Enterprise Value
$147.36M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
